Usana Health Sciences (USNA) Stock
US nutritional supplement maker with independent distributor network. Here's the price, business snapshot, and what's worth knowing about Usana Health Sciences in October 2026.
USANA Health Sciences (USNA) is a US-based maker of nutritional supplements, personal care products and weight-management items, sold primarily through a direct-selling (independent distributor) model. Investors should note its reliance on distributor recruitment and repeat consumer sales, with meaningful geographic exposure to Asia Pacific markets which have been key revenue drivers. With a market capitalisation of about $384.26m, USNA sits in the small-cap range and can show higher volatility than larger peers. Key attractions include brand recognition in targeted markets, recurring consumable sales and potential leverage from international expansion. Key risks are regulatory scrutiny of direct-selling practices, competition from other supplement brands and sensitivity to consumer spending, foreign exchange and input-cost pressures. Earnings can be lumpy and growth often depends on distributor trends rather than purely retail metrics. This is general educational information, not personal financial advice — suitability depends on an investor’s goals, time horizon and risk tolerance.
Usana Health Sciences (USNA) Stock Forecast
Analyst price target, next 12 months
$45.00
+203.6% vs today's $14.82
Price range over the last 12 months
Close to its 12-month low
Analysts covering Usana Health Sciences have a consensus 12-month target of $45.00, above the current price of $14.82.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 25 May 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying USANA's stock with a target price of $45, indicating strong growth potential.
Financial Health
USANA is performing well with strong profit margins and steady revenue, indicating healthy financial stability.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Why You’ll Want to Watch This Stock
Direct-selling model
The independent-distributor approach can create recurring sales and fast local growth, though performance hinges on recruitment and retention trends which can be uneven.
Asian market exposure
Significant revenue comes from Asia Pacific markets, offering growth potential but also exposure to currency shifts and regional regulatory changes.
Margins and costs
Margins depend on product mix, promotion and input costs; supply or pricing pressure can squeeze profitability, so watch cost control and pricing strategy.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
